ÑÇÖÞAV

Michelle S. Williams, assistant professor in the Department of Global and Community Health, shares important facts about breast cancer that are often misconstrued or misunderstood.

A $1.57 million grant from the Department of Army, U.S. Army Medical Research Acquisition Activity, will help support a transformative approach for breast cancer treatment developed by scientists in Mason’s Center for Drug Discovery for Rare Diseases.

Bioengineers find solutions to some of the world’s grand problems. But sometimes, it takes collaboration with scientists to find out the questions that need to be answered to properly apply and maximize these engineering solutions.

New research led by ÑÇÖÞAV’s College of Health and Human Services faculty Dr. Michelle Williams assessed African American breast cancer survivors’ risk factors and knowledge about cardiovascular disease in the Deep South. They found that although African American breast cancer survivors have a higher prevalence of CVD risk factors, their knowledge about CVD is low.